The AHA submitted comments June 26 to the House Ways and Means Subcommittee on Health for a hearing about improving value-based care. The AHA shared principles Congress should consider when designing alternative payment models to make participation more attractive for potential participants. Those principles include providing an adequate on-ramp and glidepath to transition to risk; including adequate risk adjustment; allowing voluntary participation and flexible design; balancing risk versus reward; and establishing guardrails to ensure participants don't compete against themselves when they achieve optimal cost savings and outcomes, among others. 

Additionally, the AHA was critical of the Centers for Medicare & Medicaid Services' newly proposed Transforming Episode Accountability Model — a mandatory bundled payment model — and suggested CMS make participation voluntary along with a host of other changes. The AHA also questioned design elements of CMS’ proposed Increasing Organ Transplant Access model, a mandatory payment model for kidney transplants. 

Related News Articles

Headline
Rep. Doris Matsui, D-Calif., and Sen. Peter Welch, D-Vt., today introduced the 340B Patients Act, AHA-supported legislation that would codify 340B providers'…
Headline
The AHA July 16 filed an amicus brief in the U.S. District Court for the District of Colorado in defense of the state’s 340B contract pharmacy law prohibiting…
Headline
Sen. Josh Hawley, R-Mo., July 15 introduced legislation that would repeal some of the Medicaid funding reductions included in the recently enacted One Big…
Headline
The U.S. District Court for the Eastern District of Missouri July 11 granted a motion by the state to dismiss claims by AbbVie that the state’s 340B contract…
Headline
The Rural Hospital Excellence in Innovation Award honors rural hospitals that are leading the way in innovative, sustainable and community-centered care. If…
Headline
The U.S. District Court for the Middle District of Tennessee June 30 denied a motion for a preliminary injunction by AbbVie in its lawsuit against the state’s…